PHQ-9 vs GAD-7: Depression vs Anxiety Screening Explained

Compare PHQ-9 (depression screening) and GAD-7 (anxiety screening). Learn when to use each tool, scoring differences, and why many professionals recommend using both together.

By Online Medical Tools Editorial TeamPublished Invalid Date

PHQ-9 vs GAD-7: Depression vs Anxiety Screening Explained

Quick Answer: PHQ-9 screens for depression (9 questions about sadness, loss of interest, sleep changes). GAD-7 screens for anxiety (7 questions about worry, nervousness, restlessness). Both use similar scoring (≥10 indicates positive screen), but they measure different conditions. Many professionals recommend using both together because depression and anxiety frequently occur together—using only one tool can miss 30-40% of people with mental health concerns.

Side-by-Side Comparison

| Feature | PHQ-9 | GAD-7 | |---------|-------|-------| | What it screens for | Depression (Major Depressive Disorder) | Generalized Anxiety Disorder (GAD) | | Number of questions | 9 items | 7 items | | Time to complete | 2-3 minutes | 1-2 minutes | | Scoring range | 0-27 | 0-21 | | Positive screen cutoff | ≥10 | ≥10 | | Severity categories | Mild (5-9), Moderate (10-14), Moderately Severe (15-19), Severe (20-27) | Mild (5-9), Moderate (10-14), Severe (15-21) | | Primary symptoms assessed | Sadness, loss of interest, sleep/appetite changes, guilt, concentration, suicidal thoughts | Worry, nervousness, restlessness, irritability, fear, trouble relaxing | | Recall period | Past 2 weeks | Past 2 weeks | | Primary care sensitivity | 88% at cutoff ≥10 | 89% at cutoff ≥10 | | Primary care specificity | 88% at cutoff ≥10 | 82% at cutoff ≥10 | | Best for monitoring | Depression treatment response | Anxiety treatment response | | Clinical use | Screening, diagnosis support, severity measurement, treatment monitoring | Screening, severity measurement, treatment monitoring | | Validated populations | Adults, adolescents (13+), primary care, specialty mental health | Adults, adolescents (13+), primary care, specialty mental health | | Free to use | Yes (public domain) | Yes (public domain) |

PHQ-9: Patient Health Questionnaire-9 (Depression Screening)

What It Measures

The PHQ-9 is a 9-item questionnaire that screens for major depressive disorder based on DSM-5 criteria. It directly corresponds to the 9 diagnostic symptoms of depression.

The 9 symptoms assessed:

Little interest or pleasure in doing things
Feeling down, depressed, or hopeless
Trouble falling/staying asleep, or sleeping too much
Feeling tired or having little energy
Poor appetite or overeating
Feeling bad about yourself (failure, letting others down)
Trouble concentrating on things
Moving/speaking slowly or being fidgety/restless
Thoughts of being better off dead or hurting yourself

How Scoring Works

Each item is scored 0-3:

0 = Not at all
1 = Several days
2 = More than half the days
3 = Nearly every day

Total score (0-27) interpretation:

0-4: Minimal or no depression
5-9: Mild depression
10-14: Moderate depression (positive screen)
15-19: Moderately severe depression
20-27: Severe depression

Positive screen threshold: ≥10 (moderate or greater depression)

Special Feature: Question 9 (Suicidal Ideation)

PHQ-9 includes a critical safety question about thoughts of self-harm or death. Any score ≥1 on Question 9 requires immediate clinical follow-up, regardless of total score.

Strengths of PHQ-9

Based on DSM-5 criteria - directly maps to diagnostic symptoms
High sensitivity and specificity (88% for both in primary care)
Dual purpose - screening and severity measurement
Can support diagnosis - provides information for clinical assessment
Widely validated - thousands of studies across populations
Monitors treatment response - repeat scores track improvement
Quick administration - 2-3 minutes

Limitations of PHQ-9

Not a diagnosis - requires clinical evaluation for confirmation
Can miss anxiety - focused on depressive symptoms only
Cultural sensitivity - some items may not translate well across cultures
Somatic symptoms - physical illness can inflate scores (fatigue, sleep, appetite)
Bipolar screening - doesn't screen for manic/hypomanic episodes

GAD-7: Generalized Anxiety Disorder-7 (Anxiety Screening)

What It Measures

The GAD-7 is a 7-item questionnaire that screens for generalized anxiety disorder. It's the most widely used brief measure for anxiety symptoms.

The 7 symptoms assessed:

Feeling nervous, anxious, or on edge
Not being able to stop or control worrying
Worrying too much about different things
Trouble relaxing
Being so restless that it's hard to sit still
Becoming easily annoyed or irritable
Feeling afraid as if something awful might happen

How Scoring Works

Each item is scored 0-3:

0 = Not at all
1 = Several days
2 = More than half the days
3 = Nearly every day

Total score (0-21) interpretation:

0-4: Minimal anxiety
5-9: Mild anxiety
10-14: Moderate anxiety (positive screen)
15-21: Severe anxiety

Positive screen threshold: ≥10 (moderate or greater anxiety)

Strengths of GAD-7

Gold standard for anxiety screening - most validated brief anxiety measure
High sensitivity (89%) and specificity (82%) in primary care
Broad anxiety detection - screens for GAD, panic disorder, social anxiety, PTSD
Quick and simple - 7 questions, 1-2 minutes
Excellent for monitoring - tracks anxiety treatment response
Well-validated - extensive research across settings and populations
Free and accessible - public domain tool

Limitations of GAD-7

Screening only - not diagnostic, requires clinical follow-up
Less specific - can detect multiple anxiety disorders (not just GAD)
Doesn't assess panic attacks - may miss specific panic disorder features
No suicidal ideation question - unlike PHQ-9, doesn't directly assess self-harm risk
Physical symptoms - can overlap with medical conditions (restlessness, fatigue)

When to Use PHQ-9

Use PHQ-9 when screening for depression or monitoring treatment:

Primary Care Screening

Annual wellness visits
Patients reporting low mood or loss of interest
Chronic disease management (diabetes, heart disease, cancer)
Postpartum depression screening

Symptoms Suggesting Depression

Persistent sadness or empty mood
Loss of interest in activities once enjoyed
Sleep changes (insomnia or hypersomnia)
Appetite/weight changes
Fatigue and low energy
Feelings of worthlessness or guilt
Difficulty concentrating or making decisions
Thoughts of death or suicide

Treatment Monitoring

Repeat PHQ-9 every 2-4 weeks during active depression treatment
Track score changes (50% reduction = treatment response)
Adjust therapy based on score trends

When to Use GAD-7

Use GAD-7 when screening for anxiety disorders or monitoring treatment:

Primary Care Screening

Annual wellness visits
Patients reporting excessive worry or nervousness
Cardiac symptoms without clear cause (anxiety-driven palpitations)
Insomnia or sleep disturbances

Symptoms Suggesting Anxiety

Excessive worry that's difficult to control
Feeling on edge or restless
Trouble relaxing
Irritability
Muscle tension
Difficulty concentrating due to worry
Sleep disturbance due to racing thoughts

Treatment Monitoring

Repeat GAD-7 every 2-4 weeks during anxiety treatment
Track score changes to assess therapy effectiveness
Adjust medication or psychotherapy based on trends

Why Use Both Together?

High Comorbidity

Depression and anxiety frequently occur together:

40-60% of people with depression also have anxiety
50-70% of people with anxiety also have depression
Research shows 34.3% of patients would be missed if only PHQ-9 was used (those with anxiety-only or mixed anxiety-depression)

Better Clinical Picture

Using both tools provides:

Comprehensive assessment - captures both mood and anxiety symptoms
Differential clarity - helps distinguish primary vs secondary symptoms
Treatment planning - informs whether to target depression, anxiety, or both
Monitoring flexibility - track both symptom domains over time

When to Administer Both

Always use both in these situations:

Initial mental health screening - comprehensive baseline
Unclear presentation - symptoms overlap between depression and anxiety
Treatment-resistant cases - may have unrecognized comorbidity
Chronic medical illness - depression and anxiety both common
Substance use patients - high rates of both conditions

The Combined PHQ-ADS Score

Some clinicians use the PHQ-ADS (Anxiety and Depression Scale), which combines PHQ-9 and GAD-7:

Total score range: 0-48 (27 from PHQ-9 + 21 from GAD-7)
Provides single measure of overall mental health symptom burden
Useful for tracking general psychological distress
Validated in multiple clinical trials

Scoring Interpretation: What to Do After Screening

PHQ-9 Score Action Steps

| Score | Severity | Recommended Action | |-------|----------|-------------------| | 0-4 | Minimal | No action needed, repeat screening annually | | 5-9 | Mild | Watchful waiting, support/education, repeat in 2 weeks | | 10-14 | Moderate | Initiate treatment (counseling or medication), follow up in 2-4 weeks | | 15-19 | Moderately Severe | Active treatment (counseling AND medication), close follow-up | | 20-27 | Severe | Immediate treatment, consider psychiatry referral, assess safety |

Any positive response to Question 9 (self-harm): Immediate safety assessment, crisis intervention if needed

GAD-7 Score Action Steps

| Score | Severity | Recommended Action | |-------|----------|-------------------| | 0-4 | Minimal | No action needed, repeat screening annually | | 5-9 | Mild | Psychoeducation, stress management, relaxation techniques, repeat in 2 weeks | | 10-14 | Moderate | Initiate treatment (counseling or medication), follow up in 2-4 weeks | | 15-21 | Severe | Active treatment (counseling AND/OR medication), consider psychiatry referral |

Clinical Scenarios: Which Tool to Use

Scenario 1: Annual Physical Exam (Healthy Adult, No Symptoms)

Recommendation: Screen with both PHQ-9 and GAD-7 for comprehensive mental health screening

Takes 3-5 minutes total
Establishes baseline scores
Detects early or subclinical symptoms
Follows preventive care guidelines

Scenario 2: Patient Reports "Feeling Down" and "Can't Sleep"

Start with: PHQ-9

Depressive symptoms are primary complaint
PHQ-9 includes sleep items
If score is positive, consider adding GAD-7 (insomnia is common in both depression and anxiety)

Scenario 3: Patient Reports "Constant Worry" and "Racing Heart"

Start with: GAD-7

Anxiety symptoms are primary complaint
GAD-7 captures worry and tension
Consider cardiac workup if palpitations are prominent
Add PHQ-9 if anxiety screen is positive (check for comorbid depression)

Scenario 4: Patient on Antidepressant for 4 Weeks, Follow-Up Visit

Use: PHQ-9 (and GAD-7 if initially elevated)

Monitor treatment response with same tool used at baseline
50% reduction in PHQ-9 score = adequate response
If score isn't improving, reassess diagnosis and treatment plan

Scenario 5: Patient with Chronic Pain, Fatigue, Poor Concentration

Use: Both PHQ-9 and GAD-7

Symptoms overlap with both depression and medical illness
Chronic pain strongly associated with depression (30-50%)
Anxiety also common in chronic illness
Distinguish psychological from purely physical symptoms

Scenario 6: College Student, Stressed About Exams, Can't Relax

Start with: GAD-7

Situational stress with anxiety symptoms
Worrying and difficulty relaxing are primary
If GAD-7 is elevated, add PHQ-9 to check for depressive symptoms
May be adjustment reaction rather than disorder (scores often normalize after stressor resolves)

Key Differences Summary

Primary Symptom Focus

PHQ-9:

Anhedonia (loss of pleasure)
Depressed mood
Sleep disturbances
Appetite changes
Guilt and worthlessness
Suicidal ideation

GAD-7:

Excessive worry
Nervousness and tension
Restlessness
Irritability
Fear and apprehension
Difficulty relaxing

Diagnostic Alignment

PHQ-9:

Directly maps to DSM-5 Major Depressive Disorder criteria
Can help support MDD diagnosis (requires 5+ symptoms including depressed mood or anhedonia)

GAD-7:

Assesses generalized anxiety symptoms
Screens broadly for multiple anxiety disorders (GAD, panic, social anxiety, PTSD)
Less specific to single DSM-5 diagnosis

Clinical Utility

PHQ-9:

Better for diagnosis support (DSM-aligned)
Includes safety screening (suicidal ideation)
More widely used in primary care

GAD-7:

Better for broad anxiety detection
Simpler and faster (7 vs 9 items)
Excellent treatment monitoring tool

Common Questions

Can I use just one instead of both?

You can, but you risk missing important symptoms. If you only have time for one, use:

PHQ-9 if depressive symptoms (sadness, loss of interest) are primary
GAD-7 if anxiety symptoms (worry, nervousness) are primary
Both for comprehensive screening (recommended)

Research shows using only PHQ-9 misses 34.3% of patients with anxiety-only or mixed anxiety-depression.

What if both scores are elevated?

This is very common (40-60% comorbidity). Next steps:

Confirm symptoms through clinical interview
Determine which is primary vs secondary
Consider combined treatment (therapy + medication targeting both)
Refer to mental health specialist if severe
Monitor both scores to track treatment response

How often should I repeat these screenings?

Initial screening:

Annually for asymptomatic adults
Every visit for high-risk populations (chronic illness, substance use, prior mental health diagnosis)

During treatment:

Every 2-4 weeks until symptoms improve
Monthly during maintenance phase
Quarterly after achieving remission

What if someone scores positive on just one question?

PHQ-9 Question 9 (suicidal ideation): Any score ≥1 requires immediate follow-up regardless of total score

Other items: Consider clinical context. One elevated item may reflect situational stress rather than disorder. Repeat screening in 1-2 weeks if concerned.

Are these tools valid for adolescents?

Yes, both are validated for ages 13+. Adolescent cutoffs are similar:

PHQ-9: ≥11 for moderate depression (slightly higher than adult cutoff)
GAD-7: ≥10 for moderate anxiety (same as adults)

For children under 13, use age-specific tools (PHQ-A, SCARED for anxiety).

Can these diagnose depression or anxiety?

No. PHQ-9 and GAD-7 are screening tools, not diagnostic tools. They identify people who may have depression or anxiety and need further evaluation. A diagnosis requires:

Clinical interview by qualified professional
Assessment of symptom duration, severity, and impairment
Exclusion of other medical/psychiatric causes
Consideration of full DSM-5 criteria

Do I need a mental health professional to administer these?

No. Both tools can be:

Self-administered by patients
Administered by nurses, medical assistants, or primary care staff
Scored immediately (simple addition)
Used in primary care, specialty care, or community settings

However, interpretation and clinical follow-up should involve a qualified healthcare provider.

What's a clinically meaningful change in score?

Treatment response benchmarks:

50% reduction = adequate treatment response
Score drops below 5 = remission
<30% reduction after 8 weeks = consider treatment change

Example: PHQ-9 score of 16 (moderately severe) dropping to 8 (mild) = good response

When to Seek Professional Help

Immediate/Urgent (Within 24 Hours)

Call 988 (Suicide & Crisis Lifeline) or go to nearest ER if:

Thoughts of suicide or self-harm
Plan or means to harm yourself
Thoughts of harming others
Severe hopelessness or worthlessness
Inability to care for yourself
Hallucinations or delusions

Prompt Evaluation (Within 1 Week)

Schedule appointment if:

PHQ-9 score ≥15 (moderately severe depression)
GAD-7 score ≥15 (severe anxiety)
Significant functional impairment (can't work, care for family, maintain relationships)
Symptoms worsening rapidly
New onset of symptoms after major life event

Routine Follow-Up (Within 2-4 Weeks)

Discuss with primary care provider if:

PHQ-9 score 10-14 (moderate depression)
GAD-7 score 10-14 (moderate anxiety)
Symptoms present for >2 weeks
Symptoms interfering with daily life
No improvement with self-care strategies

The Best Approach: Use Both Together

For comprehensive mental health screening, the best practice is:

Administer both PHQ-9 and GAD-7 at initial screening (takes 3-5 minutes total)
Identify primary symptoms - which domain is more elevated?
Check for comorbidity - are both scores elevated?
Create treatment plan targeting depression, anxiety, or both
Monitor with both tools during treatment (repeat every 2-4 weeks)
Track response - look for 50% score reduction as goal
Adjust treatment if scores aren't improving after 4-8 weeks

This approach:

Captures 100% of patients with depression or anxiety (vs 65.7% with PHQ-9 alone)
Provides complete symptom profile
Guides treatment selection
Enables precise monitoring
Improves clinical outcomes

Remember: These are screening tools, not substitutes for professional evaluation. Always follow up positive screens with clinical assessment and appropriate treatment.

Key Takeaways

✅ PHQ-9 screens for depression (9 items, focuses on sadness, loss of interest, guilt, suicidal thoughts)

✅ GAD-7 screens for anxiety (7 items, focuses on worry, nervousness, restlessness)

✅ Both use ≥10 as positive screen cutoff, but score ranges differ (PHQ-9: 0-27, GAD-7: 0-21)

✅ Depression and anxiety co-occur in 40-60% of cases - using both tools is best practice

✅ 34.3% of patients are missed if only PHQ-9 is used (those with anxiety-only or mixed symptoms)

✅ PHQ-9 includes suicide screening (Question 9 requires immediate follow-up if positive)

✅ Both are screening tools, not diagnostic tools - positive screens need clinical follow-up

✅ Repeat every 2-4 weeks during treatment to monitor response (50% reduction = adequate response)

✅ Both are free, validated, and quick (3-5 minutes total for both)

✅ Use together for comprehensive screening, or use individually based on primary symptoms

Related Tools

PHQ-9 Calculator - Screen for depression severity
GAD-7 Calculator - Screen for anxiety severity
Mental Health Screening Guide - Complete guide to PHQ-9, GAD-7, and other tools

Sources

Disclaimer: The PHQ-9 and GAD-7 are screening tools for educational and informational purposes. They are not substitutes for professional medical advice, diagnosis, or treatment. If you have concerns about depression or anxiety, consult with a qualified healthcare provider. If you are experiencing suicidal thoughts, call 988 (Suicide & Crisis Lifeline) immediately.

Disclaimer: This tool is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about your health.